CON: Therapy for a Patient With Platinum-Resistant/Refractory Ovarian Cancer Should Not be Selected Based on Results of an In Vitro Extreme Drug Sensitivity/Resistance Assay

CON: Therapy for a Patient With Platinum-Resistant/Refractory Ovarian Cancer Should Not be Selected Based on Results of an In Vitro Extreme Drug Sensitivity/Resistance Assay

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Clinical Ovarian Cancer - Volume 4, Issue 2, December 2011, Pages 57-61

John Farley, Michael J. Birrer,